未知股票 HLXB 深 沪
已收盘 08-11 16:00:00 美东时间
9.90
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 9.90
- 总市值 2.33亿
- 52周最高 --
- 市盈率 静 30.62
- 换手率 0.00%
- 52周最低 --
- 委 比 0.00%
- 总股本 2350.90万
- 历史最高 --
- 量 比 0
- 振 幅 0.00%
- 历史最低 --
- 每 手 1
- 风险率 0.08%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Helix Acquisition Corp. II Retains 60% Trust Funds
Helix Acquisition Corp. II Class A ( ($HLXB) ) just unveiled an announcement. O...
2025-08-06 19:59
Helix SPAC Keeps $120M in Trust as Merger With Cancer Drugmaker BBOT Moves Ahead With $382M in Funding
Helix Acquisition Corp. II ("Helix") (NASDAQ:HLXB), a special purpose acquisition company sponsored by affiliates of Cormorant Asset Management, and TheRas, Inc. (d/b/a BridgeBio Oncology Therapeutics) ("BBOT"), a
2025-08-06 19:38
Helix Acquisition Corp. II Retains More than 60% of Trust Account after Redemptions in connection with Business Combination with BridgeBio Oncology Therapeutics
Helix Acquisition Corp. II retained $120 million in its trust account after public shareholders redeemed approximately 39% of shares, resulting in a total of $382 million in gross proceeds, including $261 million from a PIPE transaction. This deal marks the 2nd lowest redemption rate for a biotech de-SPAC transaction since 2022.
2025-08-06 11:33
Helix Acquisition Corp. II Merger with BridgeBio Approved
Helix Acquisition Corp. II Class A ( ($HLXB) ) just unveiled an announcement. O...
2025-07-11 20:18
Helix Acquisition Corp. II Announces Merger with BridgeBio
Helix Acquisition Corp. II Class A ( ($HLXB) ) just unveiled an update. On Febr...
2025-02-28 21:29
Helix Acquisition Corp. II Prices Upsized $160M Initial Public Offering Of 16M Cass A Ordinary Shares At $10/Share
Helix Acquisition Corp. II (the "Company") announced today that it priced its upsized initial public offering of 16,000,000 Class A ordinary shares at $10.00 per share. The shares will be listed on
2024-02-09 20:37
